Bromfenac Sodium
Brand name: Prolensa
Rank #289 of 500 drugs by total cost
$40.8M
Total Cost
121,284
Total Claims
$40.8M
Total Cost
2,024
Prescribers
$336
Cost per Claim
65,070
Beneficiaries
152,037
30-Day Fills
$20K
Avg Cost/Provider
60
Avg Claims/Provider
About Bromfenac Sodium
Bromfenac Sodium (sold as Prolensa) was prescribed 121,284 times by 2,024 Medicare Part D providers in 2023, costing the program $40.8M. At $336 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
| 288 | Pitavastatin Calcium (Livalo) | $40.8M | 69,636 |
| 289 | Bromfenac Sodium (Prolensa) | $40.8M | 121,284 |
| 290 | Suvorexant (Belsomra) | $40.7M | 87,327 |
| 291 | Atogepant (Qulipta) | $40.7M | 32,955 |
| 292 | Obeticholic Acid (Ocaliva) | $40.6M | 4,131 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology